ICIPE is a leading international scientific research institute headquartered in Nairobi, Kenya, dedicated to the study of insects and other arthropods. Founded in 1970, the center operates under a unique '4-H' paradigm, which integrates Human, Animal, Plant, and Environmental Health to address the interlinked challenges of poverty, food insecurity, and disease in the tropics. It is the only international institution in sub-Saharan Africa working primarily on arthropods.
In the pharmaceutical and biotech context, ICIPE focuses on vector-borne disease control, bioprospecting for medicinal compounds, and the development of biopesticides. Its research spans from basic molecular biology and genomics to the commercialization of nature-based solutions. The center is a key player in global health, particularly in the management of malaria, neglected tropical diseases (NTDs), and emerging infectious diseases through innovative strategies like transmission-blocking microbes and pheromone-based traps.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Infectious Disease Research & Agricultural Biotech
SIZE & FINANCIALS
Employees:501-1000
Revenue:$10M-$50M
Founded:1970
Ownership:nonprofit
Status:operating
FUNDING
Stage:Non-profit / Grant-funded
Total Raised:$43.8M (2024 Revenue)
Investors:Swedish International Development Cooperation Agency (Sida), Bill & Melinda Gates Foundation, Good Ventures Foundation, European Union, Government of Kenya, Swiss Agency for Development and Cooperation (SDC), UK Foreign, Commonwealth & Development Office (FCDO)
PIPELINE
Stage:Discovery|Preclinical|Phase 2
Lead Drug Stage:Phase 2 (Herbal remedy for Tungiasis)
Modalities:Small molecule, Biopesticides, Semiochemicals, Microbial symbionts, Pheromones, Botanical extracts
Active Trials:2
Trial Phases:Phase 2: 1 | Phase 4: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:BioInnovate Africa, Regional Scholarship and Innovation Fund (RSIF)
Key Partnerships:Real IPM Ltd (Commercialization partner for biopesticides), The Alliance of Bioversity International and CIAT (Climate-resilient research), World Health Organization (WHO) (Malaria and NTD programs), KEMRI (Kenya Medical Research Institute) (Clinical trials)
COMPETITION
Position:Leader
Competitors:International Livestock Research Institute (ILRI), International Institute of Tropical Agriculture (IITA), World Agroforestry (ICRAF), CABI (Centre for Agriculture and Bioscience International)
LEADERSHIP
Key Executives:
Dr. Abdou Tenkouano - Director General
Dr. Sunday Ekesi - Deputy Director General, Research for Development
Scientific Founders:Prof. Thomas Risley Odhiambo, Prof. Carl Djerassi
Board Members:Dr. Ylva Hillbur (Chair, Governing Council), Dr. Jacqueline d'Arros Hughes (Vice Chair, Governing Council), Prof. Faith Osier (Chair, Programme Committee)
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with International Centre of Insect Physiology and Ecology (ICIPE). The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.